Page last updated: 2024-08-23

triclabendazole and ici 204,219

triclabendazole has been researched along with ici 204,219 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bawaskar, P; Brummel, BE; Chiu, TL; Grant, BD; Lewis, AK; Lo, CH; Sachs, JN; Schaaf, TM; Thomas, DD; Vunnam, N	1

Other Studies

1 other study(ies) available for triclabendazole and ici 204,219

Article	Year
An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors. SLAS discovery : advancing life sciences R & D, 2017, Volume: 22, Issue:8 Topics: Biosensing Techniques; Dimerization; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; HEK293 Cells; High-Throughput Screening Assays; Humans; Indoles; Ligands; Molecular Docking Simulation; Mutant Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylcarbamates; Protein Domains; Proteolysis; Receptors, Tumor Necrosis Factor; Signal Transduction; Small Molecule Libraries; Sulfonamides; Tosyl Compounds; Triclabendazole	2017

Article

Year

An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors.

SLAS discovery : advancing life sciences R & D, 2017, Volume: 22, Issue:8

Topics: Biosensing Techniques; Dimerization; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; HEK293 Cells; High-Throughput Screening Assays; Humans; Indoles; Ligands; Molecular Docking Simulation; Mutant Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylcarbamates; Protein Domains; Proteolysis; Receptors, Tumor Necrosis Factor; Signal Transduction; Small Molecule Libraries; Sulfonamides; Tosyl Compounds; Triclabendazole

2017